In the single EV assay, we detected more PS-exposing m/lEVs from both cancer cell lines than non-cancerous cells by dual-labeling m/lEVs with anti-annexin A1 antibodies and PS-binding proteins. This evidence concerns the gene ANXA1 and cancer.